Los Angeles, CA, United States of America

Teshome L Aboye

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Southern California. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Teshome L Aboye. Retrieved from https://idiyas.com/inventor/teshome-l-aboye

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Teshome L Aboye: Innovator in Cyclotide Research

Introduction

Teshome L Aboye is a prominent inventor based in Los Angeles, California. He has made significant contributions to the field of biochemistry, particularly in the development of novel therapeutic agents. His work focuses on cyclotides, which are cyclic peptides with potential applications in medicine.

Latest Patents

Teshome L Aboye holds a patent for "Proteolically resistant cyclotides with angiotensin 1-7 like activity." This innovative cyclotide is designed to activate the MAS1 receptor, which is associated with angiotensin-(1-7). The implications of this research are profound, as it may lead to new treatments for cancer and myocardial infarction.

Career Highlights

Aboye is affiliated with the University of Southern California, where he conducts his research. His academic background and expertise have positioned him as a leader in his field. His work not only advances scientific knowledge but also has the potential to impact patient care positively.

Collaborations

Some of his notable coworkers include Julio A Camarero Palao and Kathleen Elizabeth Rodgers. Their collaborative efforts contribute to the ongoing research and development of cyclotide-based therapies.

Conclusion

Teshome L Aboye's innovative work in cyclotide research exemplifies the intersection of science and medicine. His contributions are paving the way for new therapeutic options that could significantly improve health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…